Skip to main content
. 2023 Jan 9;95(2):e28445. doi: 10.1002/jmv.28445

Table 2.

Patient characteristics for nasopharyngeal swab samples

Variable SARS‐CoV‐2 SARS‐CoV‐2 p Value
negative (n = 12) positive (n = 54)
Age (years), mean (SD) 57.63 (17.87) 64.34 (13.68) 0.241
Sex: Male, n (%) 4 (33.33) 30 (55.56) 0.283
BMI, mean (SD) 26.58 (7.49) 29.57 (8.08) 0.178
Race: African American, n (%) 3 (25) 42 (77.78) 0.001a
Current smoker: Yes, n (%) 0 (0) 7 (12.96) 0.330a
Hospitalization, n (%) 2 (16.67) 54 (100) <0.001a
Ventilator, n (%) 1 (8.33) 16 (29.63) 0.163a
Death due to COVID, n (%) 0 (0) 6 (11.11) 0.582a
Chronic pulmonary disease: Yes, n (%)b 1 (10) 15 (31.91) 0.253a
Congestive heart failure: Yes, n (%)b 0 (0) 12 (25.53) 0.1a
Diabetes: Yes, n (%)b 2 (20) 29 (61.7) 0.032a
Obesity: Yes, n (%)b 2 (20) 6 (12.77) 0.619a
Hypertension: Yes, n (%)b 4 (40) 34 (72.34) 0.069a

Note: Significance was evaluated on the basis of the Mann–Whitney U test and the χ 2 test or Fisher's exact test.

Abbreviations: COVID, coronavirus disease 2019; SARS‐CoV‐2, severe acute respiratory syndrome coronavirus 2.

a

p Value calculated using Fisher's exact test.

b

Two missing values in SARS‐CoV‐2‐negative group and seven missing values in SARS‐CoV‐2‐positive group.